Filter
700
Filtered Results: 700
Text search:
cutanea
Featured
Recommendations
91
New Publications
141
Language
Document type
No document type
369
Guidelines
150
Studies & Reports
76
Manuals
34
Strategic & Response Plan
19
Fact sheets
17
Resource Platforms
9
Videos
9
Training Material
8
Brochures
4
Infographics
3
Situation Updates
2
Countries / Regions
Global
44
Congo, Democratic Republic of
34
India
32
Senegal
26
Burkina Faso
21
Guinea
17
Latin America and the Carribbean
15
South Africa
14
Kenya
13
Côte d’Ivoire / Ivory Coast
13
Mali
12
Western and Central Europe
11
Ethiopia
10
Nepal
9
Benin
9
Nigeria
9
Africa
9
Niger
8
Rwanda
7
Cameroon
7
Tanzania
7
Syria
6
Haiti
6
West and Central Africa
6
Brazil
6
Chad
6
Myanmar / Burma
6
Morocco
5
Cambodia
5
East and Southern Africa
5
Bangladesh
5
Uganda
5
Ghana
4
Togo
4
Mozambique
4
Middle East and North Africa
4
Paraguay
4
Eastern Europe
4
Sudan
4
Sierra Leone
3
Malawi
3
Venezuela
3
Jordan
3
Saudi Arabia
3
South–East Asia Region
3
Lebanon
3
Iraq
3
Somalia
3
Madagascar
3
Colombia
2
Turkey
2
Iran
2
Philippines
2
Germany
2
Zambia
2
South Sudan
2
Indonesia
2
Liberia
2
Pakistan
2
North Macedonia
1
Ukraine
1
Lesotho
1
Gambia
1
China
1
Albania
1
Canada
1
Afghanistan
1
Burundi
1
Peru
1
Zimbabwe
1
Qatar
1
USA
1
Asia
1
Western Pacific Region
1
France
1
Tunisia
1
Portugal
1
Spain
1
Bolivia
1
Argentina
1
Djibouti
1
Namibia
1
Egypt
1
Yemen
1
Romania
1
Greece
1
Palestine
1
Georgia
1
Central African Republic
1
Angola
1
Libya
1
Authors & Publishers
Publication Years
Category
Countries
206
Clinical Guidelines
150
Public Health
40
Women & Child Health
31
Key Resources
16
Pharmacy & Technologies
7
Capacity Building
4
Toolboxes
NTDs
119
Ebola
58
Rapid Response
46
COVID-19
42
TB
37
HIV
29
Pharmacy
26
Caregiver
23
AMR
18
Mental Health
15
Zika
12
Specific Hazards
11
Planetary Health
9
Conflict
9
Refugee
8
Disability
7
NCDs
5
Global Health Education
5
Natural Hazards
4
Polio
3
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating...
WASH and Health working together: a ‘how-to’ guide for neglected tropical disease programmes
recommended
2nd edition. This toolkit provides step-by-step guidance to NTD programme managers and partners on how to engage and work collaboratively with the WASH community to improve delivery of water, sanitation and hygiene services to underserved population affected by many neglected tropical diseases. The ...
Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u...
Due to high routine vaccination coverage, overall counts of diphtheria case have significantly declined in the Western Pacific Region recently. However, diphtheria is still prevalent in several countries and areas of the Region and remains a public health issue due to its high case fatality rate.
...
Les activités menées au cours de l'année 2022 ont été effectuées dans le cadre de la mise en œuvre de la stratégie de coopération OMS -Burundi 2019 – 2023 et en accord avec les quatre axes stratégiques qui soustendent le Budget-Programme 2022-2023.
Ce Budget-Programme (BP) est issu du 1...
Les médicaments ont été classés à la fois par classe pharmaco-thérapeutique et par ordre alphabétique. La présence d’une marque astérisque renvoie à davantage de précision pour le (les) médicament(s) concerné(s).
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust about the response activities within the communities affected.
Infection prevention and control (IP...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
Many features of the environment have been found to exert an important influence on cardiovascular disease (CVD) risk, progression, and severity. Changes in the environment due to migration to different geographic locations, modifications in lifestyle choices, and shifts in social policies and cultu...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
En 2023, la nouvelle stratégie de Coopération de l’OMS avec le Niger 2023-2027 a été lancée, assortie d’un plan d’investissement. En outre, l’OMS a soutenu plusieurs initiatives majeures du pays, comme le lancement effectif de la Stratégie nationale de la Couverture Sanitaire Universel...
The article focuses on "The State of the World’s Children 2023" report published by UNICEF. It highlights the critical role of vaccines in saving lives and the challenges in global immunization efforts, especially for marginalized and underserved children. The report emphasizes the impact of COVID...
Diabetes is a major public health problem. The rising incidence of Diabetes Type 2 is related to the effects of urbanization and unhealthy lifestyles. Research studies show that healthy eating and regular physical activity can prevent or delay the onset of Diabetes Type 2, even in high-risk individu...
Smallpox eradication was certified in 1980. Mpox has been endemic in Central and West African countries since it was first detected in 1958 . It is a zoonosis; cases are often found close to tropical rainforests where various animals carry the orthopoxvirus that causes the disease. In endemic countr...
Les médicaments essentiels sont ceux qui répondent aux besoins de santé prioritaires d'une population. Conformément aux recommandations de l'Organisation mondiale de la Santé (OMS), des listes nationales de médicaments essentiels sont régulièrement révisées, puis mises à la disposition de...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare level. This document includes treatment protocols ...
This document defines the framework for Malawi’s National HIV Programs. Considering public health benefits and risks, as well as funding and resource implications, deviations from these guidelines are not supported by the Ministry of Health.
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...
